Journal of Medical Ethics 35 (2):97-99 (2009)

Authors
David M. Shaw
University of Basel
Abstract
Kihlbom has recently argued that a system of seeking negatively informed consent might be preferable in some cases to the ubiquitous informed consent model. Although this theory is perhaps not powerful enough to supplant informed consent in most settings, it lends strength to Evans’ and Hungin’s proposal that it can be ethical to prescribe placebos rather than "active" drugs. This paper presents an argument for using negatively informed consent for the specific purpose of authorising the use of placebos in clinical contexts.
Keywords Consent  Placebos  Clinical care
Categories (categorize this paper)
DOI 10.1136/jme.2008.025700
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 55,935
Through your library

References found in this work BETA

Principles of Biomedical Ethics.Tom L. Beauchamp - 1979 - Oxford University Press.
The Ethics of the Placebo in Clinical Practice.P. Lichtenberg - 2004 - Journal of Medical Ethics 30 (6):551-554.
Autonomy and Negatively Informed Consent.Ulrik Kihlbom - 2008 - Journal of Medical Ethics 34 (3):146-9.

Add more references

Citations of this work BETA

Unethical Aspects of Homeopathic Dentistry.David Shaw - 2010 - British Dental Journal 209 (10):493-496.

Add more citations

Similar books and articles

Analytics

Added to PP index
2009-02-10

Total views
129 ( #74,455 of 2,403,172 )

Recent downloads (6 months)
2 ( #361,711 of 2,403,172 )

How can I increase my downloads?

Downloads

My notes